Neuraxis (NRXS) EBIT (2022 - 2025)

Neuraxis has disclosed EBIT across 4 years of filings, most recently posting -$1.7 million for Q4 2025.

• In Q4 2025, EBIT fell 17.07% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at -$7.8 million (down 9.4% YoY), while the FY2025 annual figure was -$7.8 million, down 9.4% from the prior year.
• EBIT came in at -$1.7 million for Q4 2025 at Neuraxis, up from -$2.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$669582.0 in Q2 2022 to a low of -$3.0 million in Q3 2023.
• Average EBIT over 4 years is -$1.6 million, with a median of -$1.7 million recorded in 2024.
• Year-over-year, EBIT slumped 151.21% in 2023 and surged 45.36% in 2024.
• Over 4 years, EBIT stood at -$986226.0 in 2022, then plunged by 64.59% to -$1.6 million in 2023, then climbed by 9.65% to -$1.5 million in 2024, then declined by 17.07% to -$1.7 million in 2025.
• Per Business Quant data, the three most recent EBIT figures were -$1.7 million in Q4 2025, -$2.1 million in Q3 2025, and -$1.7 million in Q2 2025.